Literature DB >> 1799443

Purpurogallin--a natural and effective hepatoprotector in vitro and in vivo.

T W Wu1, L H Zeng, J Wu, D Carey.   

Abstract

Purpurogallin is a plant phenol that is sometimes added as an oxidation retardant to fats-oils or to certain fuels or lubricants. However, it was unknown if purpurogallin is cytoprotective. Here we examined this issue, both in isolated hepatocytes and in vivo. From 0.5 to 2.0 mM, purpurogallin prolongs survival of rat hepatocytes substantially against oxyradicals generated with xanthine oxidase and hypoxanthine. The protection was dose dependent and surpassed that given by such antioxidants as ascorbate, mannitol, superoxide dismutase, catalase, and Trolox, when each was examined at or near its optimal concentration in the same system. When 1.5, 3, and 6 mumol of purpurogallin in saline were infused into rats with postischemic livers shortly before reperfusion, the mean hepatic salvages were 42, 76, and 86%, respectively. Such salvage effects would rank purpurogallin highly among the hepatoprotectors known. Over the range of 31 to 500 microM, purpurogallin inhibited the rate of O2 consumption in the xanthine oxidase reaction by approximately 90%, which was 2- to several-fold higher than the inhibition elicited by allopurinol over the same concentrations. Thus, purpurogallin is an effective natural hepatoprotector that may operate partly or principally as an inhibitor of xanthine oxidase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1799443     DOI: 10.1139/o91-113

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  Identification of inhibitors for single-stranded DNA-binding proteins in eubacteria.

Authors:  Jason G Glanzer; Jennifer L Endres; Brendan M Byrne; Shengqin Liu; Kenneth W Bayles; Greg G Oakley
Journal:  J Antimicrob Chemother       Date:  2016-09-08       Impact factor: 5.790

2.  Conversion of lignin-derived 3-methoxycatechol to the natural product purpurogallin using bacterial P450 GcoAB and laccase CueO.

Authors:  Shun Zhang; Xiaofeng Wu; Yi Xiao
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-31       Impact factor: 4.813

3.  Purpurogallin Reverses Neuronal Apoptosis and Enhances "M2" Polarization of Microglia Under Ischemia via Mediating the miR-124-3p/TRAF6/NF-κB Axis.

Authors:  Zongxin Cheng; Xinming Li; Xiaohua Ye; Rong Yu; Youqing Deng
Journal:  Neurochem Res       Date:  2022-09-21       Impact factor: 4.414

4.  A New Approach for Quantifying Purpurogallin in Brewed Beverages Using LC-MS in Combination with Solid Phase Extraction.

Authors:  Yu-Chen Liao; Taejo Kim; Juan L Silva; Bang-Yuan Chen
Journal:  Foods       Date:  2022-05-16

5.  Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals.

Authors:  K Prasad; R Kapoor; P Lee
Journal:  Mol Cell Biochem       Date:  1994-10-12       Impact factor: 3.396

6.  Evaluation of hydroxyl radical-scavenging property of purpurogallin using high pressure liquid chromatography.

Authors:  K Prasad; V A Laxdal
Journal:  Mol Cell Biochem       Date:  1994-06-29       Impact factor: 3.396

7.  Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.

Authors:  Kiryeong Kim; Tae Hoon Kim; Hye Jung Ihn; Jung Eun Kim; Je-Yong Choi; Hong-In Shin; Eui Kyun Park
Journal:  Int J Mol Sci       Date:  2018-02-17       Impact factor: 5.923

8.  Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.